Bile salt hydrolase-overexpressing
HepG2 cell
Lactobacillus
bile salt hydrolase
cholesterol
hepatic lipid accumulation
non-alcoholic fatty liver disease
Journal
Food & nutrition research
ISSN: 1654-661X
Titre abrégé: Food Nutr Res
Pays: Sweden
ID NLM: 101488795
Informations de publication
Date de publication:
2020
2020
Historique:
received:
02
11
2019
revised:
23
05
2020
accepted:
03
06
2020
entrez:
7
12
2020
pubmed:
8
12
2020
medline:
8
12
2020
Statut:
epublish
Résumé
Non-alcoholic fatty liver disease (NAFLD) includes a range of liver diseases that occur in the absence of significant alcohol consumption. The probiotic bacterial strains This study aimed to investigate the effects of A HepG2 cell model of OA-induced steatosis and cholesterol-induced cholesterol accumulation was developed. OA- and cholesterol-treated HepG2 cells were incubated with Both Both
Sections du résumé
BACKGROUND
BACKGROUND
Non-alcoholic fatty liver disease (NAFLD) includes a range of liver diseases that occur in the absence of significant alcohol consumption. The probiotic bacterial strains
OBJECTIVE
OBJECTIVE
This study aimed to investigate the effects of
DESIGN
METHODS
A HepG2 cell model of OA-induced steatosis and cholesterol-induced cholesterol accumulation was developed. OA- and cholesterol-treated HepG2 cells were incubated with
RESULTS
RESULTS
Both
CONCLUSION
CONCLUSIONS
Both
Identifiants
pubmed: 33281535
doi: 10.29219/fnr.v64.3751
pii: 3751
pmc: PMC7681781
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
© 2020 Wenli Huang et al.
Déclaration de conflit d'intérêts
There are no conflicts of interest to declare. The authors have not received any funding or benefits from industry or elsewhere to conduct this study.
Références
Semin Liver Dis. 2015 Aug;35(3):221-35
pubmed: 26378640
Biochim Biophys Acta. 2015 Sep;1852(9):1765-78
pubmed: 26027904
Clin Gastroenterol Hepatol. 2006 Sep;4(9):1154-61
pubmed: 16904946
Biomed Rep. 2013 Jan;1(1):71-76
pubmed: 24648896
J Clin Invest. 2006 Jul;116(7):1776-83
pubmed: 16823475
Food Funct. 2019 Sep 1;10(9):5843-5852
pubmed: 31464316
Dig Dis. 2010;28(1):155-61
pubmed: 20460905
Microbiol Spectr. 2017 Jun;5(3):
pubmed: 28643627
Hippokratia. 2009 Jan;13(1):9-19
pubmed: 19240815
J Nat Prod. 2014 Apr 25;77(4):842-7
pubmed: 24597776
Microbiome. 2018 Oct 16;6(1):182
pubmed: 30326954
J Lipid Res. 2015 Feb;56(2):201-2
pubmed: 25527605
Dig Dis Sci. 2012 Feb;57(2):545-53
pubmed: 21901256
Eur J Clin Nutr. 2010 Jun;64(6):636-43
pubmed: 20216555
Am J Transl Res. 2010 Jan 01;2(1):95-104
pubmed: 20182586
Biotechnol Bioeng. 2009 Apr 1;102(5):1466-74
pubmed: 19061238
Annu Rev Pathol. 2010;5:145-71
pubmed: 20078219
Biotechnol Adv. 2018 May - Jun;36(3):682-690
pubmed: 29248683
Int J Endocrinol. 2013;2013:450639
pubmed: 23653642
Gastroenterology. 2017 Apr;152(5):1126-1138.e6
pubmed: 28065787
Aliment Pharmacol Ther. 2014 Jun;39(11):1276-85
pubmed: 24738701
Endocr Rev. 1999 Oct;20(5):649-88
pubmed: 10529898
Gut. 2017 Jan;66(1):180-190
pubmed: 27646933
Int J Mol Sci. 2013 Oct 30;14(11):21489-503
pubmed: 24177568
Proc Natl Acad Sci U S A. 1998 May 26;95(11):5987-92
pubmed: 9600904
PLoS Pathog. 2019 Mar 7;15(3):e1007581
pubmed: 30845232
Curr Drug Targets. 2015;16(12):1324-31
pubmed: 25882223
Cell Metab. 2012 May 2;15(5):665-74
pubmed: 22560219
Hepatology. 2001 Dec;34(6):1158-63
pubmed: 11732005
Clin Sci (Lond). 2004 Jun;106(6):635-43
pubmed: 14720121
J Microbiol Biotechnol. 2015 Oct;25(10):1697-701
pubmed: 26165315
Am J Pathol. 2006 Sep;169(3):846-60
pubmed: 16936261
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Cell Metab. 2011 Apr 6;13(4):376-388
pubmed: 21459323
Anticancer Res. 2007 Mar-Apr;27(2):873-81
pubmed: 17465214
Cardiovasc Endocrinol. 2017 May 17;6(2):62-72
pubmed: 31646122
Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14
pubmed: 24912386
Mol Nutr Food Res. 2018 Dec;62(24):e1800728
pubmed: 30346664
Endocrinology. 2001 Jan;142(1):229-40
pubmed: 11145586
Probiotics Antimicrob Proteins. 2019 Sep;11(3):785-793
pubmed: 30229515